Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion type Assertion NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_head.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion description "[Po-husk, apart from lowering LDL-C, also reduced TG, TG related to certain gene variants, TC, Apo B-100, oxLDL, insulin-resistance and systolic BP in mild-moderate hypercholesterolaemic individuals. Thus, the target patients to receive Po-husk would be th]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion evidence source_evidence_literature NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion SIO_000772 20413122 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion wasDerivedFrom gad-20150221 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion wasGeneratedBy ECO_0000203 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.